Platform technology based on NG capture-c technique computational pipelines and experimental know-how.

Vigilance monitoring systems.

Development of geothermal technologies

Specialise in applying state-of-the-art mass spectrometry platforms to characterising intact protein assemblies, often referred to as native mass spectrometry.

Image analysis.

OpenClinical’s transparent AI care apps present the right pathway for each case, and explain every decision

Laser fabrication in diamond structures.

Light-emitting materials. In 2002 Opsys Ltd was acquired by Cambridge Display.

Peptide display company identifying potential peptide drugs for a range of chronic diseases

Promote a culture of responsible research and innovation in information and communications technology and other areas of technology, research and innovation through its support for, continuation and expansion of the Observatory for Responsible Research and Innovation project.

building a scalable, modular and flexible quantum computing platform.

Design oligonucleotide drugs that can activate expression of specific genes using a novel gene regulatory mechanism.

The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation. The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs.

Researches, designs and will market diagnostic tests for the measurement of clinical bio markers that reduce healthcare costs and improve patient outcomes.

Oxbotica. Robotics, autonomous systems, driverless pods.

Gene/Drug Development

Gene-based therapeutics

Oxbridge Pulsar Sources (OPS) is researching and developing novel radio transmitting antennas, based on new principles.

To provide data curation and maintenance services to commercial entities involved in carbon offset markets.

To optimise the catalyst performance and highlight the advantages of a catalyst to create green fuel for the aviation sector through carbon capture.